GlassScriptPhysician profile
Michael J Worsey
NPI 1629091145
$3,245.57
in general payments reported to CMS, 2019-2025
13 companies · $37.78 in 2025
The $37.78 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $1,312 · 2021: $157 · 2022: $87.19 · 2023: $1,146 · 2024: $95.65 · 2025: $37.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $975 · Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $975.00 |
| Food and Beverage | $304.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $1,077.50 | 2020 | |
| Medtronic, INC. | $975.00 | 2023 | |
| Ethicon US, LLC | $464.03 | 2019-2025 | Proximate, Echelon Flex, Harmonic |
| Intuitive Surgical, INC. | $426.38 | 2019-2023 | Da Vinci Surgical System |
| Ferring Pharmaceuticals INC. | $44.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.47 | 2020-2021 | |
| Heron Therapeutics, INC. | $41.91 | 2021-2022 | |
| Conmed Corporation | $37.62 | 2020 | |
| Histosonics, INC. | $35.07 | 2024 | |
| Integra Lifesciences Corporation | $28.53 | 2022 | |
| Coloplast Corp | $25.30 | 2023 | Sensura Mio |
| Tela Bio, INC. | $25.17 | 2021 | |
| Acera Surgical, INC. | $20.10 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Worsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.